Literature DB >> 35090034

CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma.

Hiroyuki Yoda1,2, William A Weiss1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35090034      PMCID： PMC9159426          DOI： 10.1093/neuonc/noac020

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  5 in total

1.  Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.

Authors:  Alice L Yu; Andrew L Gilman; M Fevzi Ozkaynak; Wendy B London; Susan G Kreissman; Helen X Chen; Malcolm Smith; Barry Anderson; Judith G Villablanca; Katherine K Matthay; Hiro Shimada; Stephan A Grupp; Robert Seeger; C Patrick Reynolds; Allen Buxton; Ralph A Reisfeld; Steven D Gillies; Susan L Cohn; John M Maris; Paul M Sondel
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

Review 2.  Neuroblastoma.

Authors:  Katherine K Matthay; John M Maris; Gudrun Schleiermacher; Akira Nakagawara; Crystal L Mackall; Lisa Diller; William A Weiss
Journal:  Nat Rev Dis Primers       Date:  2016-11-10       Impact factor: 52.329

Review 3.  Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.

Authors:  Adam J Wolpaw; Richard Bayliss; Gabriele Büchel; Chi V Dang; Martin Eilers; W Clay Gustafson; Gwenn H Hansen; Natalia Jura; Stefan Knapp; Mark A Lemmon; David Levens; John M Maris; Ronen Marmorstein; Steven J Metallo; Julie R Park; Linda Z Penn; Michael Rape; Martine F Roussel; Kevan M Shokat; William P Tansey; Kliment A Verba; Seychelle M Vos; William A Weiss; Elmar Wolf; Yaël P Mossé
Journal:  Cancer Res       Date:  2021-01-28       Impact factor: 12.701

Review 4.  Beyond the Role of CD55 as a Complement Component.

Authors:  So Hee Dho; Jae Cheong Lim; Lark Kyun Kim
Journal:  Immune Netw       Date:  2018-02-20       Impact factor: 5.851

5.  CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma.

Authors:  F Cimmino; M Avitabile; L Pezone; G Scalia; D Montanaro; M Andreozzi; L Terracciano; A Iolascon; M Capasso
Journal:  Oncogenesis       Date:  2016-04-04       Impact factor: 7.485
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.